Clinical Trials Arena January 12, 2026
GlobalData

Healthcare is moving its focus from the sheer quantity of real-world data (RWD) to quality, prioritizing project-specific solutions, flexible platforms, targeted AI, and greater transparency and adaptability in decision-making. Let’s explore the top trends we’re expecting to see in 2026.

Real-world data (RWD) is transforming healthcare by the changing priorities of pharma companies and the growing influence of AI, with notable advances expected in 2026. RWD encompasses health information gathered beyond clinical trials, such as electronic health records, insurance claims, public health systems, and from wearable devices. However, rather than just collecting huge data sets, the focus has shifted towards securing more high quality, representative data, which can be used for specific research applications.

This move away from collating as...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Clinical Trials, Technology, Trends
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs
Trial acceleration: AI supports progress, relationships drive success
Walmart Health Research Institute to Host Clinical Trials at 4 New Sites
Walmart To Launch Clinical Research Sites In Shuttered Health Clinics
2026: The time for AI to really deliver

Share Article